# A Trial of SHR-1703 in Healthy Subjects

> **NCT04855591** · PHASE1 · TERMINATED · sponsor: **Atridia Pty Ltd.** · enrollment: 1 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** SHR-1703
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04855591
- **Lead sponsor:** Atridia Pty Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-06-14
- **Primary completion:** 2021-09-13
- **Final completion:** 2021-11-18
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Adjustment of the clinical development plan for this product globally
- **Last updated:** 2021-12-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04855591

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04855591, "A Trial of SHR-1703 in Healthy Subjects". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04855591. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*